Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04829994 · ClinicalTrials.gov registry record

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

A clinical trial of Stress Urinary Incontinence, sponsored by Ethicon.

Active
Registry status
198
Enrollment target
8
Study locations

NCT04829994 is a study of Stress Urinary Incontinence that is active but no longer recruiting, run by Ethicon. The registered enrollment target is 198 participants, above the 157-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (26% higher). The trial reports 8 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04829994, a study of Stress Urinary Incontinence, is active but no longer recruiting, sponsored by Ethicon.

ACTIVE NOT RECRUITING
Registry status
198 participants
Enrollment target
8
Study locations

Study Summary

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retropubic mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

Interventions

  • DEVICE Intervention

Study Locations (8)

Other

  • Ordensklinikum Linz - Linz
  • Herlev Hospital - Hillerød
  • Hopital Jeanne de Flandres - Lille
  • Universitatsklinikum Tubingen - Tübingen
  • Karolinska Institute - Stockholm

Pennsylvania

  • Institute for Female Pelvic Medicine - North Wales
  • UPMC - Pittsburgh

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 198 participants
Start Date 2021-07-07
Est. Completion 2035-09-30

Sponsor

Ethicon

38 total trials

What the Registry Record Tells You About NCT04829994

The ClinicalTrials.gov registry entry for NCT04829994 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 157-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (26% higher). The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Intervention is the first listed.

NCT04829994 reports 8 study locations spanning 3 distinct geographic areas - top geographies include Other, Pennsylvania, North Carolina.

Frequently Asked Questions

What is clinical trial NCT04829994 about?

NCT04829994 is a clinical study titled "Post-Market Clinical Follow-Up onTVT EXACT® Continence System". The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retropubic mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

What is the current status of trial NCT04829994?

This trial is currently active not recruiting. The enrollment target is 198 participants. The study started on 2021-07-07. Estimated completion is 2035-09-30.

What conditions does trial NCT04829994 study?

This clinical trial studies the following conditions: Stress Urinary Incontinence.

What interventions are being tested in trial NCT04829994?

The interventions under investigation include: Intervention (DEVICE).

Who is sponsoring clinical trial NCT04829994?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04829994 being conducted?

This trial has 8 study locations across North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.